Data / Form D filings / Lucy Therapeutics, Inc.
Lucy Therapeutics, Inc.: Form D filings
Lucy Therapeutics, Inc., a pharmaceuticals company in Waltham, MA, filed 5 Form D notices with the SEC between 2019 and 2024. The latest, on May 2, 2024, reports $10.6 million sold of a $10.6 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 21 Hickory Drive, Suite 2B, Waltham, MA, 02451
- Phone
- (617) 249-4812
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1782250
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 2, 2024 | Amendment | $10,552,797 | $10,552,797 | 6 | Dec 15, 2023 | sec.gov | |
| Dec 26, 2023 | New notice | $9,000,000 | $3,449,999 | $5,550,001 | 3 | Dec 15, 2023 | sec.gov |
| Jan 6, 2022 | New notice | $20,000,000 | $15,044,707 | $4,955,293 | 5 | Dec 22, 2021 | sec.gov |
| Jul 22, 2020 | Amendment | $4,509,472 | $3,019,999 | $1,489,473 | 4 | Jun 28, 2019 | sec.gov |
| Jul 15, 2019 | New notice | $3,500,000 | $2,914,590 | $585,410 | 3 | Jun 28, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Rachel Sha | Director | |
| Robert Michael Poole | Director | |
| Amy Ripka | Executive Officer, Director | |
| John Ripple | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Apr 29, 2024 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Lucy Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.